17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review
Keywords: Bioidentical hormones; 17β-Estradiol; Menopause; Progesterone; Vasomotor symptoms; CBHT; compounded bioidentical hormone therapy; CEE; conjugated equine estrogens; EMA; European Medicines Agency; FDA; Food and Drug Administration; HDL-C; high-density lip